169 related articles for article (PubMed ID: 21922275)
1. Promoter methylation status and expression of estrogen receptor alpha in familial breast cancer patients.
Wei J; Han B; Mao XY; Wei MJ; Yao F; Jin F
Tumour Biol; 2012 Apr; 33(2):413-20. PubMed ID: 21922275
[TBL] [Abstract][Full Text] [Related]
2. Silencing of estrogen receptor alpha (ERalpha) gene by promoter hypermethylation is a frequent event in Chinese women with sporadic breast cancer.
Zhao L; Wang L; Jin F; Ma W; Ren J; Wen X; He M; Sun M; Tang H; Wei M
Breast Cancer Res Treat; 2009 Sep; 117(2):253-9. PubMed ID: 18814026
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor-alpha promoter methylation in sporadic basal-like breast cancer of Chinese women.
Jing MX; Mao XY; Li C; Wei J; Liu C; Jin F
Tumour Biol; 2011 Aug; 32(4):713-9. PubMed ID: 21625942
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor alpha (ERα) promoter methylation status in tumor and serum DNA in Egyptian breast cancer patients.
Hagrass HA; Pasha HF; Ali AM
Gene; 2014 Nov; 552(1):81-6. PubMed ID: 25218234
[TBL] [Abstract][Full Text] [Related]
5. Constitutive expression of AhR and BRCA-1 promoter CpG hypermethylation as biomarkers of ERα-negative breast tumorigenesis.
Romagnolo DF; Papoutsis AJ; Laukaitis C; Selmin OI
BMC Cancer; 2015 Dec; 15():1026. PubMed ID: 26715507
[TBL] [Abstract][Full Text] [Related]
6. CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis.
Ramezani F; Salami S; Omrani MD; Maleki D
Asian Pac J Cancer Prev; 2012; 13(2):451-7. PubMed ID: 22524805
[TBL] [Abstract][Full Text] [Related]
7. Association of promoter methylation of ERα and ERβ with sporadic breast cancer--a study from North India.
Chattopadhyay S; Deo SV; Shukla NK; Husain SA
Tumour Biol; 2014 Aug; 35(8):7911-9. PubMed ID: 24833090
[TBL] [Abstract][Full Text] [Related]
8. BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers.
Vos S; Moelans CB; van Diest PJ
Breast Cancer Res; 2017 May; 19(1):64. PubMed ID: 28569220
[TBL] [Abstract][Full Text] [Related]
9. Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients.
Mirza S; Sharma G; Prasad CP; Parshad R; Srivastava A; Gupta SD; Ralhan R
Life Sci; 2007 Jul; 81(4):280-7. PubMed ID: 17599361
[TBL] [Abstract][Full Text] [Related]
10. The effect of modifiable potentials on hypermethylation status of retinoic acid receptor-beta2 and estrogen receptor-alpha genes in primary breast cancer.
Pirouzpanah S; Taleban FA; Atri M; Abadi AR; Mehdipour P
Cancer Causes Control; 2010 Dec; 21(12):2101-11. PubMed ID: 20711807
[TBL] [Abstract][Full Text] [Related]
11. [Study of the CpG methylation status of ER alpha gene in estrogen receptor alpha-negative breast cancer cell lines and the role of hydralazine demethylation].
Tang B; Jiang J
Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):283-7. PubMed ID: 16181550
[TBL] [Abstract][Full Text] [Related]
12. Different methylation and microRNA expression pattern in male and female familial breast cancer.
Pinto R; Pilato B; Ottini L; Lambo R; Simone G; Paradiso A; Tommasi S
J Cell Physiol; 2013 Jun; 228(6):1264-9. PubMed ID: 23160909
[TBL] [Abstract][Full Text] [Related]
13. DNA hypermethylation of ESR1 and PGR in breast cancer: pathologic and epidemiologic associations.
Gaudet MM; Campan M; Figueroa JD; Yang XR; Lissowska J; Peplonska B; Brinton LA; Rimm DL; Laird PW; Garcia-Closas M; Sherman ME
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3036-43. PubMed ID: 19861523
[TBL] [Abstract][Full Text] [Related]
14. ERα propelled aberrant global DNA hypermethylation by activating the DNMT1 gene to enhance anticancer drug resistance in human breast cancer cells.
Si X; Liu Y; Lv J; Ding H; Zhang XA; Shao L; Yang N; Cheng H; Sun L; Zhu D; Yang Y; Li A; Han X; Sun Y
Oncotarget; 2016 Apr; 7(15):20966-80. PubMed ID: 26980709
[TBL] [Abstract][Full Text] [Related]
15. Association of poor prognosis subtypes of breast cancer with estrogen receptor alpha methylation in Iranian women.
Izadi P; Mehrdad N; Foruzandeh F; Reza NM
Asian Pac J Cancer Prev; 2012; 13(8):4113-7. PubMed ID: 23098526
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of Stratifin, ERalpha and PR promoter methylation in tumor and serum DNA in Indian breast cancer patients.
Mirza S; Sharma G; Parshad R; Srivastava A; Gupta SD; Ralhan R
Clin Biochem; 2010 Mar; 43(4-5):380-6. PubMed ID: 19961842
[TBL] [Abstract][Full Text] [Related]
17. Reprimo, a Potential p53-Dependent Tumor Suppressor Gene, Is Frequently Hypermethylated in Estrogen Receptor α-Positive Breast Cancer.
Buchegger K; Riquelme I; Viscarra T; Ili C; Brebi P; Huang TH; Roa JC
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28809778
[TBL] [Abstract][Full Text] [Related]
18. A multigenic study on breast cancer risk associated with genetic polymorphisms of ER Alpha, COMT and CYP19 gene in BRCA1/BRCA2 negative Shanghai women with early onset breast cancer or affected relatives.
Hu Z; Song CG; Lu JS; Luo JM; Shen ZZ; Huang W; Shao ZM
J Cancer Res Clin Oncol; 2007 Dec; 133(12):969-78. PubMed ID: 17562079
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous CXCL12 and ESR1 CpG island hypermethylation correlates with poor prognosis in sporadic breast cancer.
Ramos EA; Camargo AA; Braun K; Slowik R; Cavalli IJ; Ribeiro EM; Pedrosa Fde O; de Souza EM; Costa FF; Klassen G
BMC Cancer; 2010 Jan; 10():23. PubMed ID: 20109227
[TBL] [Abstract][Full Text] [Related]
20. Interaction of TFAP2C with the estrogen receptor-alpha promoter is controlled by chromatin structure.
Woodfield GW; Hitchler MJ; Chen Y; Domann FE; Weigel RJ
Clin Cancer Res; 2009 Jun; 15(11):3672-9. PubMed ID: 19458056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
